Diffusion-weighted MR imaging of the liver

Radiology

Volumn 254, Issue 1, 2010, Pages 47-66

  Taouli, Bachir ^a   Koh, Dow Mu ^b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM CHELATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE PROCESSING; IMAGE QUALITY; LIVER ADENOMA; LIVER CELL CARCINOMA; LIVER CYST; LIVER DISEASE; LIVER HEMANGIOMA; LIVER METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPRODUCIBILITY; REVIEW; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER DISEASES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 75349104448     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.09090021     Document Type: Review

References (140)

1. Le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986;161:401-407.
2. Moseley ME, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion-and T2-weighted MRI and spectroscopy. Magn Reson Med 1990;14:330-346.
3. Moseley ME, Kucharczyk J, Mintorovitch J, et al. Diffusion-weighted MR imaging of acute stroke: correlation with T2-weighted and magnetic susceptibility-enhanced MR imaging in cats. AJNR Am J Neuroradiol 1990;11:423-429.
4. Moseley ME, Mintorovitch J, Cohen Y, et al. Early detection of ischemic injury: comparison of spectroscopy, diffusion-, T2-, and magnetic susceptibility-weighted MRI in cats. Acta Neurochir Suppl (Wien) 1990;51:207-209.
5. Sevick RJ, Kucharczyk J, Mintorovitch J, Moseley ME, Derugin N, Norman D. Diffusion-weighted MR imaging and T2-weighted MR imaging in acute cerebral ischaemia: comparison and correlation with histopathology. Acta Neurochir Suppl (Wien) 1990;51:210-212.
6. Warach S, Chien D, Li W, Ronthal M, Edelman RR. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 1992;42:1717-1723.
7. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331-345.
8. Le Bihan D, Mangin JF, Poupon C, et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001;13:534-546.
9. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 2006;21:1104-1108.
10. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006;17:2359-2362.
11. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology 2007;243:148-157.
12. Thomsen HS, Marckmann P, Logager VB. Update on nephrogenic systemic fibrosis. Magn Reson Imaging Clin N Am 2008;16:551-560.
13. Le Bihan D. Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q 1991;7:1-30.
14. Bammer R. Basic principles of diffusion-weighted imaging. Eur J Radiol 2003;45:169-184.
15. Nicholson C, Phillips JM. Ion diffusion modified by tortuosity and volume fraction in the extracellular microenvironment of the rat cerebellum. J Physiol 1981;321:225-257.
16. Szafer A, Zhong J, Anderson AW, Gore JC. Diffusion-weighted imaging in tissues: theoretical models. NMR Biomed 1995;8:289-296.
17. Koh DM, Collins DJ. Diffusion-weighted MRI in the body:applications and challenges in oncology. AJR Am J Roentgenol 2007;188:1622-1635.
18. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys 1965;42:288-292.
19. Chenevert TL, Brunberg JA, Pipe JG. Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology 1990;177:401-405.
20. Turner R, Le Bihan D, Maier J, Vavrek R, Hedges LK, Pekar J. Echo-planar imaging of intravoxel incoherent motion. Radiology 1990;177:407-414.
21. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G. Diffusion tensor MR imaging of the human brain. Radiology 1996; 201:637-648.
22. Moseley ME, Cohen Y, Kucharczyk J, et al. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology 1990;176:439-445.
23. Damon BM, Ding Z, Anderson AW, Freyer AS, Gore JC. Validation of diffusion tensor MRI-based muscle fiber tracking. Magn Reson Med 2002;48:97-104.
24. Ries M, Jones RA, Basseau F, Moonen CT, Grenier N. Diffusion tensor MRI of the human kidney. J Magn Reson Imaging 2001;14:42-49.
25. Notohamiprodjo M, Glaser C, Herrmann KA, et al. Diffusion tensor imaging of the kidney with parallel imaging:initial clinical experience. Invest Radiol 2008;43:677-685.
26. Bammer R, Auer M, Keeling SL, et al. Diffusion tensor imaging using single-shot SENSE-EPI. Magn Reson Med 2002;48:128-136.
27. Bammer R, Augustin M, Strasser-Fuchs S, et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med 2000;44:583-591.
28. Chepuri NB, Yen YF, Burdette JH, Li H, Moody DM, Maldjian JA. Diffusion anisotropy in the corpus callosum. AJNR Am J Neuroradiol 2002;23:803-808.
29. Dong Q, Welsh RC, Chenevert TL, et al. Clinical applications of diffusion tensor imaging. J Magn Reson Imaging 2004;19:6-18.
30. Taber KH, Pierpaoli C, Rose SE, et al. The future for diffusion tensor imaging in neuropsychiatry. J Neuropsychiatry Clin Neurosci 2002;14:1-5.
31. Taouli B, Martin AJ, Qayyum A, et al. Parallel imaging and diffusion tensor imaging for diffusion-weighted MRI of the liver: preliminary experience in healthy volunteers. AJR Am J Roentgenol 2004;183:677-680.
32. Taouli B, Chouli M, Martin AJ, Qayyum A, Coakley FV, Vilgrain V. Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 2008;28:89-95.
33. Gurses B, Kabakci N, Kovanlikaya A, et al. Diffusion tensor imaging of the normal prostate at 3 Tesla. Eur Radiol 2008;18:716-721.
34. Manenti G, Carlani M, Mancino S, et al. Diffusion tensor magnetic resonance imaging of prostate cancer. Invest Radiol 2007;42:412-419.
35. Taouli B, Vilgrain V, Dumont E, Daire JL, Fan B, Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echoplanar MR imaging sequences:prospective study in 66 patients. Radiology 2003;226:71-78.
36. Le Bihan D, Breton E, Lallemand D, Aubin ML, Vignaud J, Laval-Jeantet M. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497-505.
37. Le Bihan D. Diffusion/perfusion MR imaging of the brain:from structure to function. Radiology 1990;177:328-329.
38. Moteki T, Horikoshi H, Oya N, Aoki J, Endo K. Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted reordered turboFLASH magnetic resonance images. J Magn Reson Imaging 2002;15:564-572.
39. Yamada I, Aung W, Himeno Y, Nakagawa T, Shibuya H. Diffusion coefficients in abdominal organs and hepatic lesions: evaluation with intravoxel incoherent motion echoplanar MR imaging. Radiology 1999;210:617-623.
40. Dixon WT. Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging: a modest proposal with tremendous potential. Radiology 1988;168:566-567.
41. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imaging-pilot study. Radiology 2008;249:891-899.
42. Le Bihan D. Intravoxel incoherent motion perfusion MR imaging:a wake-up call. Radiology 2008;249:748-752.
43. Ichikawa T, Haradome H, Hachiya J, Nitatori T, Araki T. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol 1998;170:397-402.
44. Kim T, Murakami T, Takahashi S, Hori M, Tsuda K, Nakamura H. Diffusion-weighted single-shot echoplanar MR imaging for liver disease. AJR Am J Roentgenol 1999;173:393-398.
45. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008; 18:477-485.
46. Gourtsoyianni S, Papanikolaou N, Yarmenitis S, Maris T, Karantanas A, Gourtsoyiannis N. Respiratory gated diffusion-weighted imaging of the liver: value of apparent diffusion coefficient measurements in the differentiation between most commonly encountered benign and malignant focal liver lesions. Eur Radiol 2008;18:486-492.
47. Koh DM, Scurr E, Collins DJ, et al. Colorectal hepatic metastases: quantitative measurements using single-shot echo-planar diffusion-weighted MR imaging. Eur Radiol 2006;16:1898-1905.
48. Stehling MK, Turner R, Mansfield P. Echoplanar imaging: magnetic resonance imaging in a fraction of a second. Science 1991; 254:43-50.
49. Butts K, Riederer SJ, Ehman RL, Felmlee JP, Grimm RC. Echo-planar imaging of the liver with a standard MR imaging system. Radiology 1993;189:259-264.
50. Turner R, Le Bihan D, Chesnick AS. Echoplanar imaging of diffusion and perfusion. Magn Reson Med 1991;19:247-253.
51. Braithwaite AC, Dale BM, Boll DT, Merkle EM. Short-and midterm reproducibility of apparent diffusion coefficient measurements at 3.0-T diffusion-weighted imaging of the abdomen. Radiology 2009;250:459-465.
52. van den Bos IC, Hussain SM, Krestin GP, Wielopolski PA. Liver imaging at 3.0 T: diffusion-induced black-blood echo-planar imaging with large anatomic volumetric coverage as an alternative for specific absorption rate-intensive echo-train spin-echo sequences:feasibility study. Radiology 2008;248:264-271.
53. Chiu FY, Jao JC, Chen CY, et al. Effect of intravenous gadolinium-DTPA on diffusion-weighted magnetic resonance images for evaluation of focal hepatic lesions. J Comput Assist Tomogr 2005;29:176-180.
54. Taouli B, Sandberg A, Stemmer A, et al. Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging 2009;30:561-568.
55. Koh DM, Takahara T, Imai Y, Collins DJ. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci 2007;6:211-224.
56. Kwee TC, Takahara T, Ochiai R, Nievelstein RA, Luijten PR. Diffusion-weighted wholebody imaging with background body signal suppression (DWIBS): features and potential applications in oncology. Eur Radiol 2008;18:1937-1952.
57. Parikh T, Drew SJ, Lee VS, et al. Focal liver lesion detection and characterization with diffusion-weighted MR imaging:comparison with standard breath-hold T2-weighted imaging. Radiology 2008;246:812-822.
58. Nasu K, Kuroki Y, Fujii H, Minami M. Hepatic pseudo-anisotropy: a specific artifact in hepatic diffusion-weighted images obtained with respiratory triggering. MAGMA 2007;20:205-211.
59. Nasu K, Kuroki Y, Sekiguchi R, Nawano S. The effect of simultaneous use of respiratory triggering in diffusion-weighted imaging of the liver. Magn Reson Med Sci 2006;5:129-136.
60. Kwee TC, Takahara T, Koh DM, Nievelstein RA, Luijten PR. Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging 2008;28:1141-1148.
61. Nasu K, Kuroki Y, Nawano S, et al. Hepatic metastases: diffusion-weighted sensitivityencoding versus SPIO-enhanced MR Imaging. Radiology 2006;239:122-130.
62. Murtz P, Flacke S, Traber F, van den Brink JS, Gieseke J, Schild HH. Abdomen: diffusion-weighted MR imaging with pulsetriggered single-shot sequences. Radiology 2002;224:258-264.
63. de Bazelaire CM, Duhamel GD, Rofsky NM, Alsop DC. MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results. Radiology 2004;230:652-659.
64. Okada Y, Ohtomo K, Kiryu S, Sasaki Y. Breath-hold T2-weighted MRI of hepatic tumors: value of echo planar imaging with diffusion-sensitizing gradient. J Comput Assist Tomogr 1998;22:364-371.
65. Hussain SM, De Becker J, Hop WC, Dwarkasing S, Wielopolski PA. Can a singleshot black-blood T2-weighted spin-echo echo-planar imaging sequence with sensitivity encoding replace the respiratorytriggered turbo spin-echo sequence for the liver? An optimization and feasibility study. J Magn Reson Imaging 2005;21:219-229.
66. Le Bihan D, Poupon C, Amadon A, Lethimonnier F. Artifacts and pitfalls in diffusion MRI. J Magn Reson Imaging 2006;24:478-488.
67. Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999;42:952-962.
68. Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med 2004;22:275-282.
69. Niendorf T, Dijkhuizen RM, Norris DG, van Lookeren Campagne M, Nicolay K. Biexponential diffusion attenuation in various states of brain tissue: implications for diffusionweighted imaging. Magn Reson Med 1996; 36:847-857.
70. Assaf Y, Cohen Y. Non-mono-exponential attenuation of water and N-acetyl aspartate signals due to diffusion in brain tissue. J Magn Reson 1998;131:69-85.
71. Gudbjartsson H, Patz S. The Rician distribution of noisy MRI data. Magn Reson Med 1995;34:910-914.
72. Sasaki M, Yamada K, Watanabe Y, et al. Variability in absolute apparent diffusion coefficient values across different platforms may be substantial: a multivendor, multiinstitutional comparison study. Radiology 2008;249:624-630.
73. Padhani AR, Liu G, Mu-Koh D, et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009;11:102-125.
74. Moteki T, Sekine T. Echo planar MR imaging of the liver: comparison of images with and without motion probing gradients. J Magn Reson Imaging 2004;19:82-90.
75. Low RN, Gurney J. Diffusion-weighted MRI (DWI) in the oncology patient: value of breathhold DWI compared to unenhanced and gadolinium-enhanced MRI. J Magn Reson Imaging 2007;25:848-858.
76. Coenegrachts K, Delanote J, Ter Beek L, et al. Improved focal liver lesion detection: comparison of single-shot diffusion-weighted echoplanar and single-shot T2 weighted turbo spin echo techniques. Br J Radiol 2007;80:524-531.
77. Koh DM, Brown G, Riddell AM, et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusionweighted imaging (DWI) alone and in combination. Eur Radiol 2008;18:903-910.
78. Bruegel M, Gaa J, Waldt S, et al. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echoplanar MRI and five t2-weighted turbo spinecho sequences. AJR Am J Roentgenol 2008;191:1421-1429.
79. Zech CJ, Herrmann KA, Dietrich O, Horger W, Reiser MF, Schoenberg SO. Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging: comparison with a standard T2-weighted sequence for detection of focal liver lesions. Invest Radiol 2008;43:261-266.
80. Furuhata T, Okita K, Tsuruma T, et al. Efficacy of SPIO-MR imaging in the diagnosis of liver metastases from colorectal carcinomas. Dig Surg 2003;20:321-325.
81. Vogl TJ, Schwarz W, Blume S, et al. Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US. Eur Radiol 2003;13:262-272.
82. Ward J, Robinson PJ, Guthrie JA, et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium-and SPIO-enhanced MR imaging. Radiology 2005;237:170-180.
83. Zech CJ, Herrmann KA, Reiser MF, Schoenberg SO. MR imaging in patients with suspected liver metastases: value of liverspecific contrast agent Gd-EOB-DTPA. Magn Reson Med Sci 2007;6:43-52.
84. Elizondo G, Fretz CJ, Stark DD, et al. Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 1991;178:73-78.
85. Beziat C, Pilleul F, Yzebe D, Lombard-Bohas C, Mercier C, Valette PJ. Detection of liver metastases in colorectal cancer on chemotherapy. comparative study between MRI with teslascan and computed tomography with intravenous contrast media [in French]. J Radiol 2004;85:307-311.
86. Kim KW, Kim AY, Kim TK, et al. Small (< or = 2 cm) hepatic lesions in colorectal cancer patients:detection and characterization on mangafodipir trisodium-enhanced MRI. AJR Am J Roentgenol 2004;182:1233-1240.
87. Regge D, Campanella D, Anselmetti GC, et al. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol 2006;61:338-347.
88. Naganawa S, Sato C, Nakamura T, et al. Diffusion-weighted images of the liver: comparison of tumor detection before and after contrast enhancement with superparamagnetic iron oxide. J Magn Reson Imaging 2005;21:836-840.
89. Kiryu S, Watanabe M, Kabasawa H, Akahane M, Aoki S, Ohtomo K. Evaluation of super paramagnetic iron oxide-enhanced diffusion-weighted PROPELLER T2-fast spin echo magnetic resonance imaging: preliminary experience. J Comput Assist Tomogr 2006;30:197-200.
90. Coenegrachts K, Matos C, Ter Beek L, et al. Focal liver lesion detection and characterization: comparison of non-contrast enhanced and SPIO-enhanced diffusionweighted single-shot spin echo echo planar and turbo spin echo T2-weighted imaging. Eur J Radiol 2008;Epub ahead of print.
91. Inan N, Arslan A, Akansel G, et al. Diffusion-weighted imaging in the differential diagnosis of simple and hydatid cysts of the liver. AJR Am J Roentgenol 2007; 189:1031-1036.
92. Muller MF, Prasad P, Siewert B, Nissenbaum MA, Raptopoulos V, Edelman RR. Abdominal diffusion mapping with use of a whole-body echo-planar system. Radiology 1994;190:475-478.
93. Demir OI, Obuz F, Sagol O, Dicle O. Contribution of diffusion-weighted MRI to the differential diagnosis of hepatic masses. Diagn Interv Radiol 2007;13:81-86.
94. Vossen JA, Buijs M, Liapi E, Eng J, Bluemke DA, Kamel IR. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions. J Comput Assist Tomogr 2008;32:750-756.
95. Goshima S, Kanematsu M, Kondo H, et al. Hepatic hemangioma:correlation of enhancement types with diffusion-weighted MR findings and apparent diffusion coefficients. Eur J Radiol 2009;70:325-330.
96. Moteki T, Ishizaka H, Horikoshi H, Matsumoto M. Differentiation between hemangiomas and hepatocellular carcinomas with the apparent diffusion coefficient calculated from turboFLASH MR images. J Magn Reson Imaging 1995;5:187-191.
97. Chan JH, Tsui EY, Luk SH, et al. Diffusion-weighted MR imaging of the liver:distinguishing hepatic abscess from cystic or necrotic tumor. Abdom Imaging 2001;26:161-165.
98. Goshima S, Kanematsu M, Kondo H, et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008;28:691-697.
99. Koinuma M, Ohashi I, Hanafusa K, Shibuya H. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis. J Magn Reson Imaging 2005;22:80-85.
100. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 2007;25:4104-4109.
101. Sharma U, Danishad KK, Seenu V, Jagannathan NR. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009;22:104-113.
102. Thoeny HC, De Keyzer F, Vandecaveye V, et al. Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging. Radiology 2005;237:492-499.
103. Mardor Y, Roth Y, Ochershvilli A, et al. Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI. Neoplasia 2004;6:136-142.
104. Patterson DM, Padhani AR, Collins DJ. Technology insight: water diffusion MRI-a potential new biomarker of response to cancer therapy. Nat Clin Pract Oncol 2008;5:220-233.
105. Geschwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 2000;11:1245-1255.
106. Deng J, Rhee TK, Sato KT, et al. In vivo diffusion-weighted imaging of liver tumor necrosis in the VX2 rabbit model at 1.5 Tesla. Invest Radiol 2006;41:410-414.
107. Yuan YH, Xiao EH, Liu JB, et al. Characteristics of liver on magnetic resonance diffusionweighted imaging: dynamic and image pathological investigation in rabbit liver VX-2 tumor model. World J Gastroenterol 2008;14:3997-4004.
108. Youn BJ, Chung JW, Son KR, et al. Diffusion-weighted MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver. Acad Radiol 2008;15:593-600.
109. Deng J, Virmani S, Young J, et al. Diffusionweighted PROPELLER MRI for quantitative assessment of liver tumor necrotic fraction and viable tumor volume in VX2 rabbits. J Magn Reson Imaging 2008;27:1069-1076.
110. Ohira T, Okuma T, Matsuoka T, et al. FDGMicroPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits. Cardiovasc Intervent Radiol 2009; 32:114-120.
111. Yuan YH, Xiao EH, Liu JB, et al. Characteristics and pathological mechanism on magnetic resonance diffusion-weighted imaging after chemoembolization in rabbit liver VX-2 tumor model. World J Gastroenterol 2007;13:5699-5706.
112. Koh DM, Scurr E, Collins D, et al. Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. AJR Am J Roentgenol 2007;188:1001-1008.
113. Cui Y, Zhang XP, Sun YS, Tang L, Shen L. Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008;248:894-900.
114. Buijs M, Vossen JA, Hong K, Georgiades CS, Geschwind JF, Kamel IR. Chemoembolization of hepatic metastases from ocular melanoma:assessment of response with contrast-enhanced and diffusion-weighted MRI. AJR Am J Roentgenol 2008;191:285-289.
115. De Santis M, Torricelli P, Cristani A, et al. MRI of hepatocellular carcinoma before and after transcatheter chemoembolization. J Comput Assist Tomogr 1993;17:901-908.
116. De Santis M, Alborino S, Tartoni PL, Torricelli P, Casolo A, Romagnoli R. Effects of lipiodol retention on MRI signal intensity from hepatocellular carcinoma and surrounding liver treated by chemoembolization. Eur Radiol 1997;7:10-16.
117. Kamel IR, Bluemke DA, Ramsey D, et al. Role of diffusion-weighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol 2003;181:708-710.
118. Kamel IR, Bluemke DA, Eng J, et al. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma. J Vasc Interv Radiol 2006;17:505-512.
119. Chen CY, Li CW, Kuo YT, et al. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization:choline levels and MR diffusion constants-initial experience. Radiology 2006;239:448-456.
120. Deng J, Miller FH, Rhee TK, et al. Diffusion-weighted MR imaging for determination of hepatocellular carcinoma response to yttrium-90 radioembolization. J Vasc Interv Radiol 2006;17:1195-1200.
121. Kamel IR, Reyes DK, Liapi E, Bluemke DA, Geschwind JF. Functional MR imaging assessment of tumor response after 90Y microsphere treatment in patients with unresectable hepatocellular carcinoma. J Vasc Interv Radiol 2007;18:49-56.
122. Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF. Unresectable hepatocellular carcinoma:serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging. Radiology 2009;250:466-473.
123. Mannelli L, Kim S, Hajdu C, Babb J, Clark TW, Taouli B. Assessment of tumor necrosis of hepatocellular carcinoma after chemo embolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol 2009;193:1044-1052.
124. Goshima S, Kanematsu M, Kondo H, et al. Evaluating local hepatocellular carcinoma recurrence post-transcatheter arterial chemoembolization: Is diffusion-weighted MRI reliable as an indicator? J Magn Reson Imaging 2008;27:834-839.
125. Namimoto T, Yamashita Y, Sumi S, Tang Y, Takahashi M. Focal liver masses:characterization with diffusion-weighted echo-planar MR imaging. Radiology 1997;204:739-744.
126. Amano Y, Kumazaki T, Ishihara M. Singleshot diffusion-weighted echo-planar imaging of normal and cirrhotic livers using a phasedarray multicoil. Acta Radiol 1998;39:440-442.
127. AubéC, Racineux PX, Lebigot J, et al. Diagnosis and quantification of hepatic fibrosis with diffusion weighted MR imaging: preliminary results [in French]. J Radiol 2004;85:301-306.
128. Lewin M, Poujol-Robert A, Boelle PY, et al. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 2007; 46:658-665.
129. Girometti R, Furlan A, Esposito G, et al. Relevance of b-values in evaluating liver fibrosis: a study in healthy and cirrhotic subjects using two single-shot spin-echo echoplanar diffusion-weighted sequences. J Magn Reson Imaging 2008;28:411-419.
130. Taouli B, Tolia AJ, Losada M, et al. Diffusion-weighted MRI for quantification of liver fibrosis:preliminary experience. AJR Am J Roentgenol 2007;189:799-806.
131. Annet L, Materne R, Danse E, Jamart J, Horsmans Y, Van Beers BE. Hepatic flow parameters measured with MR imaging and Doppler US:correlations with degree of cirrhosis and portal hypertension. Radiology 2003;229:409-414.
132. Hagiwara M, Rusinek H, Lee VS, et al. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging-initial experience. Radiology 2008;246:926-934.
133. Annet L, Peeters F, Abarca-Quinones J, Leclercq I, Moulin P, Van Beers BE. Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 2007; 25:122-128.
134. Coenegrachts K, Delanote J, Ter Beek L, et al. Evaluation of true diffusion, perfusion factor, and apparent diffusion coefficient in non-necrotic liver metastases and uncomplicated liver hemangiomas using blackblood echo planar imaging. Eur J Radiol 2009;69:131-138.
135. Bammer R, Keeling SL, Augustin M, et al. Improved diffusion-weighted single-shot echoplanar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med 2001;46:548-554.
136. Lee VS, Hecht EM, Taouli B, Chen Q, Prince K, Oesingmann N. Body and cardiovascular MR imaging at 3.0 T. Radiology 2007;244:692-705.
137. Barth MM, Smith MP, Pedrosa I, Lenkinski RE, Rofsky NM. Body MR imaging at 3.0 T: understanding the opportunities and challenges. RadioGraphics 2007;27:1445-1462; discussion 1462-1464.
138. Deng J, Miller FH, Salem R, Omary RA, Larson AC. Multishot diffusion-weighted PROPELLER magnetic resonance imaging of the abdomen. Invest Radiol 2006;41:769-775.
139. Deng J, Omary RA, Larson AC. Multishot diffusion-weighted SPLICE PROPELLER MRI of the abdomen. Magn Reson Med 2008; 59:947-953.
140. Talwalkar JA. Elastography for detecting hepatic fibrosis:options and considerations. Gastroenterology 2008;135:299-302.